Css LLC Allakos Inc. Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.08 - $9.81 $1,828 - $3,531	-360 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $8,037 - $105,176	-940 Reduced 72.31%	360 $4,000
Q3 2020 Nov 16, 2020	SELL	$66.43 - $90.99 $66,430 - $90,990	-1,000 Reduced 43.48%	1,300 $106,000
Q2 2020 Aug 14, 2020	SELL	$44.04 - $80.69 $149,075 - $273,135	-3,385 Reduced 59.54%	2,300 $165,000
Q1 2020 May 15, 2020	BUY	$44.49 - $93.39 $208,435 - $437,532	4,685 Added 468.5%	5,685 $253,000
Q4 2019 Feb 14, 2020	BUY	$66.49 - $137.73 $66,490 - $137,730	1,000 New	1,000 $95,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $88.1M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.